These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22553358)

  • 1. Endomorphin-2: a biased agonist at the μ-opioid receptor.
    Rivero G; Llorente J; McPherson J; Cooke A; Mundell SJ; McArdle CA; Rosethorne EM; Charlton SJ; Krasel C; Bailey CP; Henderson G; Kelly E
    Mol Pharmacol; 2012 Aug; 82(2):178-88. PubMed ID: 22553358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies.
    Xie H; Woods JH; Traynor JR; Ko MC
    Anesth Analg; 2008 Jun; 106(6):1873-81. PubMed ID: 18499626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of G Protein-Coupled Receptor Kinases 2 and 3 in μ-Opioid Receptor Desensitization and Internalization.
    Lowe JD; Sanderson HS; Cooke AE; Ostovar M; Tsisanova E; Withey SL; Chavkin C; Husbands SM; Kelly E; Henderson G; Bailey CP
    Mol Pharmacol; 2015 Aug; 88(2):347-56. PubMed ID: 26013542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
    Melkes B; Hejnova L; Novotny J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G protein activation by endomorphins in the mouse periaqueductal gray matter.
    Narita M; Mizoguchi H; Narita M; Dun NJ; Hwang BH; Endoh T; Suzuki T; Nagase H; Suzuki T; Tseng LF
    J Biomed Sci; 2000; 7(3):221-5. PubMed ID: 10810240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor constants for endomorphin-1 and endomorphin-1-ol indicate differences in efficacy and receptor occupancy.
    Al-Khrasani M; Orosz G; Kocsis L; Farkas V; Magyar A; Lengyel I; Benyhe S; Borsodi A; Rónai AZ
    Eur J Pharmacol; 2001 Jun; 421(1):61-7. PubMed ID: 11408050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent inflammatory pain decreases the antinociceptive effects of the mu opioid receptor agonist DAMGO in the locus coeruleus of male rats.
    Jongeling AC; Johns ME; Murphy AZ; Hammond DL
    Neuropharmacology; 2009; 56(6-7):1017-26. PubMed ID: 19265713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. μ-opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization.
    McPherson J; Rivero G; Baptist M; Llorente J; Al-Sabah S; Krasel C; Dewey WL; Bailey CP; Rosethorne EM; Charlton SJ; Henderson G; Kelly E
    Mol Pharmacol; 2010 Oct; 78(4):756-66. PubMed ID: 20647394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endomorphin-1: induction of motor behavior and lack of receptor desensitization.
    Mehta A; Bot G; Reisine T; Chesselet MF
    J Neurosci; 2001 Jun; 21(12):4436-42. PubMed ID: 11404430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.
    Johnson EA; Oldfield S; Braksator E; Gonzalez-Cuello A; Couch D; Hall KJ; Mundell SJ; Bailey CP; Kelly E; Henderson G
    Mol Pharmacol; 2006 Aug; 70(2):676-85. PubMed ID: 16682505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro.
    Knapman A; Santiago M; Connor M
    Br J Pharmacol; 2015 May; 172(9):2258-72. PubMed ID: 25521224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and internalization of the mu-opioid receptor by the newly discovered endogenous agonists, endomorphin-1 and endomorphin-2.
    McConalogue K; Grady EF; Minnis J; Balestra B; Tonini M; Brecha NC; Bunnett NW; Sternini C
    Neuroscience; 1999 Mar; 90(3):1051-9. PubMed ID: 10218804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. μ-Opioid receptor desensitization: homologous or heterologous?
    Llorente J; Lowe JD; Sanderson HS; Tsisanova E; Kelly E; Henderson G; Bailey CP
    Eur J Neurosci; 2012 Dec; 36(12):3636-42. PubMed ID: 23002724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein-coupled receptor kinase 2 mediates mu-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus.
    Li AH; Wang HL
    J Neurochem; 2001 Apr; 77(2):435-44. PubMed ID: 11299306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mu-opioid receptor gene-dose dependent reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in mu-opioid receptor knockout mice.
    Mizoguchi H; Narita M; Oji DE; Suganuma C; Nagase H; Sora I; Uhl GR; Cheng EY; Tseng LF
    Neuroscience; 1999; 94(1):203-7. PubMed ID: 10613510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endomorphins fully activate a cloned human mu opioid receptor.
    Gong J; Strong JA; Zhang S; Yue X; DeHaven RN; Daubert JD; Cassel JA; Yu G; Mansson E; Yu L
    FEBS Lett; 1998 Nov; 439(1-2):152-6. PubMed ID: 9849897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycinergic inputs to cardiac vagal neurons in the nucleus ambiguus are inhibited by nociceptin and mu-selective opioids.
    Venkatesan P; Baxi S; Evans C; Neff R; Wang X; Mendelowitz D
    J Neurophysiol; 2003 Sep; 90(3):1581-8. PubMed ID: 12761284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist Binding and Desensitization of the μ-Opioid Receptor Is Modulated by Phosphorylation of the C-Terminal Tail Domain.
    Birdsong WT; Arttamangkul S; Bunzow JR; Williams JT
    Mol Pharmacol; 2015 Oct; 88(4):816-24. PubMed ID: 25934731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.